SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation

Area of Science:

• Stem cell biology
• Molecular biology
• Gerontology

Background:

• Mesenchymal stem cells (MSCs) show therapeutic potential but suffer from interdonor variability and decreased function with aging and ex vivo expansion.
• Sirtuins, particularly Sirtuin 3 (SIRT3), are involved in aging, metabolism, and oxidative stress, with SIRT3 levels declining with age.

Purpose of the Study:

• To investigate the role of SIRT3 in the aging and differentiation of MSCs.
• To determine if SIRT3 modulation can improve MSC quality for clinical applications.

Main Methods:

• Cultured MSCs and monitored SIRT3 levels during ex vivo expansion.
• Assessed MSC differentiation into adipocytes and osteoblasts following SIRT3 depletion or overexpression.
• Evaluated senescence and oxidative stress markers in aged MSCs with altered SIRT3 levels.

Main Results:

• SIRT3 levels decreased as MSCs were expanded ex vivo.
• Depletion of SIRT3 impaired MSC differentiation into adipocytes and osteoblasts.
• Overexpression of SIRT3 in aged MSCs reduced senescence, decreased oxidative stress, and improved differentiation capacity.

Conclusions:

• SIRT3 plays a critical role in maintaining MSC differentiation potential and mitigating aging-related decline.
• Overexpressing SIRT3 in MSCs presents a promising strategy to enhance their therapeutic efficacy for clinical use.